Literature DB >> 2118723

Treatment of ocular disease in eczema herpeticum.

T P Margolis1, H B Ostler.   

Abstract

Individuals with atopic dermatitis are particularly susceptible to herpes simplex viral infection and may develop dissemination (eczema herpeticum). Additionally, they may develop severe and bilateral herpetic ocular disease. The keratitis is commonly complicated by stromal scarring and slow epithelial healing despite topical antiviral therapy. We treated three patients who had herpetic keratoconjunctivitis associated with eczema herpeticum. In all three cases the keratitis resolved promptly (48 to 72 hours) without residual scarring after treatment with systemic acyclovir and topical trifluridine. The combined use of systemic acyclovir and topical trifluridine may be of similar value in treating all cases of atopic herpetic keratitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118723     DOI: 10.1016/s0002-9394(14)76344-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.

Authors:  Y F Yao; Y Inoue; T Kase; Y Uchihori; Y Mori; Y Ohashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 2.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

3.  [Eczema herpeticum: Pathogenesis and therapy].

Authors:  H C Rerinck; S Kamann; A Wollenberg
Journal:  Hautarzt       Date:  2006-07       Impact factor: 1.198

4.  Disseminated mucocutaneous herpes simplex in an atopic individual.

Authors:  C Wilde; W Sheehan; A Shepherdson; A Patwardhan
Journal:  JRSM Short Rep       Date:  2011-10-18

5.  A 33-year-old man with a facial rash.

Authors:  John Fleming; William A Lynn
Journal:  PLoS Med       Date:  2004-11-30       Impact factor: 11.069

Review 6.  Adoption of Innovation in Herpes Simplex Virus Keratitis.

Authors:  James Chodosh; Lawson Ung
Journal:  Cornea       Date:  2020-11       Impact factor: 3.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.